Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01324271 · ClinicalTrials.gov registry record · NA
inVENT-In-Office Study
A NA study, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT01324271 is a NA study that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 85 participants.
The verdict
NCT01324271, a NA study, has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
The objective of the study is to evaluate the safety and efficacy of the Acclarent Tympanostomy Tube Delivery System (TTDS) for the placement of tympanostomy tubes (TT) under local anesthesia in an office/clinic setting.
Interventions
- DEVICE Acclarent Tympanostomy Tube Delivery system (TTDS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01324271
The ClinicalTrials.gov registry entry for NCT01324271 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acclarent Tympanostomy Tube Delivery system (TTDS) is the first listed.
NCT01324271 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01324271 about?
NCT01324271 is a clinical study titled "inVENT-In-Office Study". The objective of the study is to evaluate the safety and efficacy of the Acclarent Tympanostomy Tube Delivery System (TTDS) for the placement of tympanostomy tubes (TT) under local anesthesia in an office/clinic setting.
What is the current status of trial NCT01324271?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2011-01. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01324271?
The interventions under investigation include: Acclarent Tympanostomy Tube Delivery system (TTDS) (DEVICE).
Who is sponsoring clinical trial NCT01324271?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.